Opendata, web and dolomites

FABER-Net

FABER-Net: A unique network of labs dedicated to the diagnosis of allergies using the innovative FABER test

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "FABER-Net" data sheet

The following table provides information about the project.

Coordinator
ALLERGY DATA LABORATORIES SRL 

Organization address
address: VIA NINO BIXIO 11
city: LATINA LT
postcode: 4100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://www.caam-allergy.com/en/faber
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLERGY DATA LABORATORIES SRL IT (LATINA LT) coordinator 50˙000.00

Map

 Project objective

Allergies are the most common chronic disease: with >1B people affected globally, of which >150M in Europe, today allergies are a worldwide epidemic. Besides clinical symptoms such as rhinitis, asthma and atopic eczema, allergies cause distress in those affected, who live in fear of an asthma attack, anaphylactic shock, or death from an allergic reaction. In addition, allergies have high costs for businesses and society: in the EU, work absenteeism of allergic patients costs €55-151B/year, while families with one allergic child or adult spend an extra €3,900-8,100/year. A high-quality and reliable allergy diagnosis is essential to identify the best treatment option for allergic patients and improve their health, and also to reduce costs. Today there are >3000 molecules known to cause allergies, but current methods for diagnosis are not able to test a high number of allergens, at a reasonable price and in a short time; also, most of them are invasive and present some risks for the patients. On top of this, every year new allergens are discovered, but they can’t be included in diagnostic tests for technical and economic reasons. To overcome these limitations ADL has created the FABER test: a multiplex system for allergy diagnosis that can test 301 allergens at the time - the highest number currently available. This is a flexible system based on nanotechnology in which the number of allergens can be increased when new ones are available. ADL aims to expand in Europe and then worldwide the network of labs that provide FABER allergy diagnosis at the most local level and with ADL’s highest testing quality. Thanks to this network (FABER-Net), the FABER test will be available for many patients suffering from allergies, who will have a more informative diagnosis, which in turn will allow a more personalized and effective treatment. This will improve the patients’ health and reduce their absenteeism from work, thus cutting costs in healthcare and associated with work absence

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FABER-NET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FABER-NET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

Reuse as a service (2019)

Reusable packaging as a service for e-commerce

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More